Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies).
Saved in:
| Title: | Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies). |
|---|---|
| Authors: | Escribano Subias P; Department of Cardiology, CIBERCV, Instituto de Investigación del Hospital Universitario 12 de Octubre, ERN-LUNG, Universidad Complutense, Madrid, Spain. pilar.escribano.subias@outlook.com., Chakinala MM; Washington University School of Medicine, St. Louis, MO, USA., Chin KM; University of Texas, Southwestern Medical Center, Dallas, TX, USA., Didden EM; Johnson & Johnson, Allschwil, Switzerland., Doad G; Johnson & Johnson, Titusville, NJ, USA., Farber HW; Tufts Medical Center, Boston, MA, USA., Gaine S; National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland., Hemnes AR; Vanderbilt University Medical Center, Nashville, TN, USA., Highland KB; Cleveland Clinic, Cleveland, OH, USA., Lange TJ; Department of Pulmonology, Bad Reichenhall Hospital, Bad Reichenhall, Germany.; Department of Internal Medicine II, Faculty of Medicine, Regensburg University, Regensburg, Germany., McLaughlin V; University of Michigan Medical Center, Ann Arbor, MI, USA., Muller A; Johnson & Johnson, Allschwil, Switzerland., Rahman M; Johnson & Johnson, Titusville, NJ, USA., Remeňová T; Johnson & Johnson, Allschwil, Switzerland., Söderberg S; Department of Public Health and Clinical Medicine, Cardiology and Heart Centre, Umeå University, Umeå, Sweden., Venkatesh A; Johnson & Johnson, Allschwil, Switzerland., Kim NH; University of California San Diego, La Jolla, CA, USA. |
| Source: | Drugs - real world outcomes [Drugs Real World Outcomes] 2026 Mar; Vol. 13 (1), pp. 85-100. Date of Electronic Publication: 2026 Jan 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101658456 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2199-1154 (Print) Linking ISSN: 21989788 NLM ISO Abbreviation: Drugs Real World Outcomes Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2199-1154 |
|---|---|
| DOI: | 10.1007/s40801-025-00536-4 |
